BPC-157 + TB-400

BPC-157 + TB-400 is Bowery Clinic’s injectable recovery-focused combination of BPC-157 and Thymosin Beta-4. BPC-157 is a 15-amino-acid peptide studied primarily in preclinical models of tendon, ligament, muscle, and gastrointestinal repair. Thymosin Beta-4 is a naturally occurring peptide involved in cell migration, actin regulation, angiogenesis, and wound-healing biology. BPC-157 research has reported effects on tendon outgrowth and cell migration study, while Thymosin Beta-4 has been studied for tissue repair and dermal healing research. The Bowery combination is intended for clinician-guided recovery and wellness goals, not as a guaranteed treatment for a specific orthopedic diagnosis.

BPC-157 + TB-400 is intended to support recovery-related signaling, especially for patients focused on tendons, ligaments, muscle, or general soft-tissue resilience. In laboratory and animal studies, BPC-157 has been associated with fibroblast migration, angiogenic signaling, and improved tendon-healing measures research. Thymosin Beta-4 has been linked with keratinocyte migration, angiogenesis, collagen deposition, and tissue repair research. Those mechanisms make the combination attractive in regenerative and wellness settings, but they should not be translated into a promise that a torn tendon, ligament injury, or chronic pain condition will heal on a specific schedule.

BPC-157 + TB-400 should be used under medical supervision. The two-peptide combination does not have the same depth of large human safety trials as conventional approved medications, so clinician screening matters. Your clinician will review current medical conditions, other medications or peptides, pregnancy status, and the reason for considering treatment. With subcutaneous injections, local irritation, bruising, or tenderness can occur. A patient who develops unusual swelling, persistent pain, rash, systemic symptoms, or a worsening of the condition being treated should contact the clinical team.

BPC-157 + TB-400 is typically assessed over 4–6 weeks. Changes in soreness, mobility, or recovery may be noticed within the first 1–2 weeks in patients who respond, while tendon and connective-tissue remodeling is a slower process. Functional improvement across the full cycle is more meaningful than a single-day response.

Bowery Clinic peptides are higher-strength and clinically dosed compared to most research facilities that use much lower concentrations. They are compounded by licensed 503A pharmacies with physician oversight and sterile quality standards, prioritizing real therapeutic outcomes over cheaper, unregulated research-grade products, and come fully prepared and ready for use — no mixing or reconstitution needed.

Yes. All pharmacies in our network are fully licensed in the states where they operate and comply with all state board of pharmacy regulations. Unlike many peptide clinics, we partner exclusively with FDA-registered U.S. pharmacies that undergo rigorous evaluation and compliance checks.

Every patient receives treatment plans developed and monitored by licensed providers. This includes safe titration of dosages and ongoing medical oversight tailored to individual needs.

Injections deliver the medication directly into your system. This makes the absorption more consistent and effective. Troches are small dissolvable lozenges that sit in your mouth until they melt, slowly releasing medication through the lining of your cheek or under your tongue.